Kimia Farma Secures Rp846 Billion Shareholder Loan for Business Restructuring

Strategic Funding to Support Operational Needs

PT Kimia Farma Tbk, a leading Indonesian pharmaceutical company, has obtained an Rp846 billion Shareholder Loan as part of its comprehensive corporate restructuring plan. This significant funding injection is designed to strengthen the company's financial foundation and support its ongoing business operations.

Enhancing Financial Stability and Growth

The Shareholder Loan represents a critical component of Kimia Farma's broader restructuring efforts, aimed at ensuring both financial stability and sustainable business growth. According to Ida Rasita, General Manager of Corporate Secretary, the additional funding will enable the company to effectively meet its operational requirements, which will have a direct positive impact on both production capacity and sales performance.

Restructuring Plan Implementation

Kimia Farma's corporate restructuring plan is a multi-faceted initiative focused on optimizing the company's overall business performance. The successful implementation of this plan, supported by the recent Shareholder Loan, is expected to position Kimia Farma for stronger future growth and improved market competitiveness in Indonesia's pharmaceutical sector.